Remission of hepatotoxicity in chronic pulmonary aspergillosis patients after lowering trough concentration of voriconazole

BACKGROUND: Chronic pulmonary aspergillosis (CPA) is a rare syndrome that is often accompanied by gradual lung tissue destruction. Voriconazole is usually employed as the first-line agent for CPA treatment. However, some patients can develop hepatotoxicity and often were forced to stop voriconazole...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Guo-Jie, Bai, Xiang-Rong, Zhang, Lin, Liu, Hong-Jun, Nie, Xiu-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642544/
https://www.ncbi.nlm.nih.gov/pubmed/33195637
http://dx.doi.org/10.12998/wjcc.v8.i20.4700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642544/
https://www.ncbi.nlm.nih.gov/pubmed/33195637
http://dx.doi.org/10.12998/wjcc.v8.i20.4700

Ejemplares similares